TAE : Tables: Adverse Events

Id Lesson SAS R SAS Video R Video
TFL_TAE_L100 1- Overview of Treatment-Emergent Adverse Events - Subject count and Event count
TFL_TAE_L101 2- Treatment emergent adverse events, by primary system organ class and preferred term
TFL_TAE_L102 3- Treatment-Emergent Adverse Events by Maximum Severity
TFL_TAE_L103 4- Treatment-Emergent Adverse Events by SOC and PT sorted by descending frequency
TFL_TAE_L103a 5- Treatment-Emergent Adverse Events by SOC and PT sorted by descending frequency - SOC repeated on page
TFL_TAE_L103b 6- Treatment-Emergent Adverse Events by SOC and PT sorted by descending frequency - SOC repeated on page
TFL_TAE_L104 7- Treatment-Emergent Adverse Events by Relationship to Study Drug
TFL_TAE_L105 8- Treatment-Emergent Adverse Events by Preferred Term - Descending frequency
TFL_TAE_L105a 9- Treatment-Emergent Adverse Events by Preferred Term
TFL_TAE_L105a1 10- Treatment-Emergent Adverse Events by Preferred Term (descending frequency)
TFL_TAE_L106 11- TEAE That Equal to or Exceed a Threshold of 5% in Any Treatment Group
TFL_TAE_L107 12- Treatment-Emergent Adverse Events by Preferred Term - with fisher exact test p-value
TFL_TAE_L107a 13- TEAE by PT - with chisq/fisher exact test p-value
TFL_TAE_L108 14- TEAE by PT - Odds Ratio
TFL_TAE_L108a 15- TEAE by PT - Odds Ratio with p-value
TFL_TAE_L109 16- TEAE by PT - Risk Ratio
TFL_TAE_L110 17- TEAE by PT - Risk Difference
TFL_TAE_L111 18- Exposure Adjusted Treatment-Emergent Adverse Event Rate by SOC and PT sorted by descending rate
TFL_TAE_L112 19- Exposure Adjusted Treatment-Emergent Adverse Subject Incidence Rate by SOC and PT sorted by descending rate
TFL_TAE_L113 20- TEAE by SOC, PT and Grade